ArticleRadiology. Imaging cancer2024
Assessing the Value of
Article in Radiology. Imaging cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Dual-Target Nectin-4/FAP Heterobivalent ProbeAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Survival benefit of ⁶⁸Ga-FAPI PET/CT staging for prognostic assessment in gastric and colorectal cancer compared with CE-CT and ¹⁸F-FDG PET/CT: a single-center retrospective study.European journal of nuclear medicine and molecular imaging · 2026Article
- Gastrointestinal cancer with indeterminateOncology letters · 2026Article
- [Scientific reports · 2026Article
- Prognostic Significance of Pretreatment [¹⁸F]ALF-NOTA-FAPI-04 PET/CT in Patients With Recurrent Gastric Cancer Undergoing Combined PD-1 Inhibitor and Chemotherapy.Korean journal of radiology · 2026Article
- Diagnostic Efficacy of FAPI-PET/CT Versus [Diagnostics (Basel, Switzerland) · 2026Review
- Article
- Ga-68 FAPI-04 PET/CT detection of repeatedly biopsy-negative poorly differentiated gastric adenocarcinoma: a case report.Frontiers in medicine · 2026Article
- Review
- Molecular Imaging in Gastric Cancer: [¹⁸F]FDG and Fibroblast Activation Protein-Targeted PET/CT.Journal of gastric cancer · 2026Review
- Characterization of Gastric Mucinous Carcinoma: Clinicopathological Insights and Vascular Features via MSCT.International journal of general medicine · 2026Article
- Synchronous gastric and appendiceal mucinous adenocarcinomas: a rare case report.Frontiers in oncology · 2026Article
- The Characteristics of Prostate Mucinous Adenocarcinoma Visualized by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT.Clinical nuclear medicine · 2025Article
- Prognostic value of [European journal of nuclear medicine and molecular imaging · 2025Article
- Preoperative [Frontiers in immunology · 2025Article
- CombinedFrontiers in medicine · 2025Article
- Hereditary diffuse gastric cancer: the evolution of a cancer syndrome.Journal of the Royal Society of New Zealand · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To investigate the clinical impact and prognostic value of gallium 68 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.